| Literature DB >> 31610608 |
Danielle Carson1, Rachael Barry1, Eve G D Hopkins1, Theodoros I Roumeliotis2, Diego García-Weber3,4,5, Caroline Mullineaux-Sanders1, Eran Elinav6, Cécile Arrieumerlou3,4,5, Jyoti S Choudhary2, Gad Frankel1.
Abstract
The mouse pathogen Citrobacter rodentium is used to model infections with enterohaemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC). Pathogenesis is commonly modelled in mice developing mild disease (e.g., C57BL/6). However, little is known about host responses in mice exhibiting severe colitis (e.g., C3H/HeN), which arguably provide a more clinically relevant model for human paediatric enteric infection. Infection of C3H/HeN mice with C. rodentium results in rapid colonic colonisation, coinciding with induction of key inflammatory signatures and colonic crypt hyperplasia. Infection also induces dramatic changes to bioenergetics in intestinal epithelial cells, with transition from oxidative phosphorylation (OXPHOS) to aerobic glycolysis and higher abundance of SGLT4, LDHA, and MCT4. Concomitantly, mitochondrial proteins involved in the TCA cycle and OXPHOS were in lower abundance. Similar to observations in C57BL/6 mice, we detected simultaneous activation of cholesterol biogenesis, import, and efflux. Distinctly, however, the pattern recognition receptors NLRP3 and ALPK1 were specifically induced in C3H/HeN. Using cell-based assays revealed that C. rodentium activates the ALPK1/TIFA axis, which is dependent on the ADP-heptose biosynthesis pathway but independent of the Type III secretion system. This study reveals for the first time the unfolding intestinal epithelial cells' responses during severe infectious colitis, which resemble EPEC human infections.Entities:
Keywords: Citrobacter rodentium; immunology; infection; metabolic processes; microbial-cell interaction
Mesh:
Year: 2019 PMID: 31610608 PMCID: PMC7003488 DOI: 10.1111/cmi.13126
Source DB: PubMed Journal: Cell Microbiol ISSN: 1462-5814 Impact factor: 3.715
Figure 1Citrobacter rodentium infection in C3H/HeN mice. Temporal faecal shedding (a), changes to body weight (b), and increased faecal water content (c) in individual infected mice. Solid connecting line indicates the mean. * P < .05 (Students t test). (d) Representative colonic sections from C3H/HeN mice stained for C. rodentium (white) and DNA (blue) at 0, 1, 2, 3, 6, and 8 DPI (n ≥ 4). Sporadic colonisation is seen at 2 DPI (arrows); uniform colonisation is seen from 3 DPI. Scale bar 200 μm. (e) Representative in vivo images of C3H/HeN mice infected with C. rodentium ICC180 showing caecal colonisation at 1 DPI and robust colonic colonisation from 3 DPI (n ≥ 7). (f) Ex vivo tissue images of three representative C3H/HeN (n = 10) and C57BL/6 mice (n = 5) at 8 DPI, showing extended colonic colonisation of the former. The scale bar in e and f indicates signal intensity (photons s−1 cm−2 sr−1). (g) Quantification of the colon length colonised by C. rodentium as depicted in (f). **** P < .0001 (Students t test)
Figure 2Citrobacter rodentium subverts metabolism and cell proliferation in C3H/HeN IECs. (a) Log2 fold change values of proteins ranked from most downregulated (left) to most upregulated (right) in abundance in infected samples compared with uninfected (top panel). KEGG pathways determined as significantly enriched following 1D enrichment analysis of the infected IEC proteome compared with uninfected samples and ranked from most negatively enriched (i.e., most downregulated; top) to most positively enriched pathways (i.e., most upregulated; bottom). Individual proteins associated with ranked KEGG pathways are highlighted in the heat‐map adjacent to the corresponding KEGG pathway (lower panel). (b) Crypt length measurements over time showing increased CCH at 3 DPI followed by a further expansion at 6 DPI (each point represents the mean crypt length of an individual mouse). (c) Quantification of the PCNA‐positive zone calculated as a percentage of the total crypt length (each point represents the mean crypt length of an individual mouse). (d) Representative immunostaining of PCNA (green), C. rodentium (pink), and DNA (blue) from C. rodentium‐infected colonic sections, showing an increased proliferation zone at 3 DPI followed by a further expansion at 6 DPI (n ≥ 4). Scale bar 50 μm
Figure 3Reprogramming of the gut epithelium during C. rodentium‐induced CCH. The protein abundance of SLC26A3, CA4, and REG4 (a) and CLCA1 and TFF3 (d) decreases, whereas that of DMBT1 increases upon infection (d). Bars indicate standard deviation. The abundance of Slc26a3 (b), Reg4 (c), and Dmbt1 (e) transcripts show a decrease in Slc26a3 and Reg4 and an increase in Dmbt1 from 3 DPI. Each point represents an individual mouse at 0, 1, 2, 3, 6, and 8 DPI. * P ≤ .05, ** P ≤ .01, *** P ≤ .001, **** P ≤ .0001 (one‐way ANOVA)
Figure 4Citrobacter rodentium induces changes to IEC metabolism. (a) The protein abundance of MCT1 decreases and SGLT4 increases upon infection of both C3H/HeN and C57BL/6 mice. The abundance of LDHA and MCT4 increases specifically in infected C3H/HeN mice. Bars indicate standard deviation. (b) The abundance of Slc5a9 transcripts (encoding SGLT4) increases from 2 DPI. (c) The abundance of Ldha transcripts increases at 8 DPI in C3H/HeN mice and decreases from 6 DPI in C57BL/6 mice. (d) The abundance of Slc16a3 transcripts (encoding MCT4) increases from 6 DPI in C3H/HeN mice and is unchanged over time in C57BL/6 mice. For all qRT‐PCR data, each point represents an individual mouse at 0, 1, 2, 3, 6, and 8 DPI. *P ≤ .05, **P ≤ .01, ***P ≤ .001, and ****P ≤ .0001 (one‐way ANOVA). (e). Relative abundancies of tissue‐associated microbiota phyla in uninfected (n = 4) and C. rodentium‐infected mice (n = 5), showing a bloom of proteobacteria and depletion of Firmicutes upon infection. *P < .05 (Mann–Whitney). (f) S. Typhimurium, but not C. rodentium, can utilise L‐lactate as a sole carbon source. Both strains can grow on minimal medium containing glucose
Figure 5Citrobacter rodentium induces changes to cholesterol homeostasis. (a) Schematic showing the regulated proteins in the cholesterol biosynthetic pathway. (b) The protein abundance of the nearly all proteins in the cholesterol biosynthetic pathway increases upon C. rodentium infection. Bars indicate standard deviation. The abundance of Ldlr (c) and Hmgcr (d) transcripts decreases at 8 DPI, respectively, whereas Pcsk9 is unchanged (e). The abundance of Abcg5 decreases from 2 DPI (f), whereas that of Abca1 increases from 6 DPI (g). Each point represents an individual mouse at 0, 1, 2, 3, 6, and 8 DPI. (h) A gradual increase in faecal cholesterol measured at 0, 3, and 6 DPI in individual mice; each point indicates an individual mouse. * P ≤ .05, ** P ≤ .01, *** P ≤ .001, and **** P ≤ .0001 (one‐way ANOVA)
Figure 6Rapid induction of IL‐22 and IFN‐γ responses occurs following C. rodentium infection. (a) The protein abundance of S100A8, S100A9, REG3γ, REG3β and MMP9, iNOS, and IDO1 increases upon infection (CXCL1 is undetected). Bars indicate standard deviation. The abundance of S100a8 (b), Reg3γ (c), Nos2 (d), and Cxcl1 (e) transcripts increase from 2 DPI, whereas Ido1 increases at 3 DPI (f). * P ≤ .05, ** P ≤ 0.01, *** P ≤ .001, and **** P ≤ .0001 (one‐way ANOVA)
Figure 7Differential regulation of ALPK1 pathway in C3H/HeN and C57BL/6 mice. (a) Schematic showing NLRP3 inflammasome (a) and ALPK1 (d) activation pathways. (b) The protein abundance of NLRP3 increases in infected C3H/HeN mice and decreases in C57BL/6. The abundance of the other inflammasome components (excluding ASC in C3H/HeN mice) do not change upon infection. Bars indicate standard deviation. (c) The abundance of Nlrp3 transcript increases in C3H/HeN mice from 6 DPI but was undetectable in IECs from C57BL/6. (e) The protein abundance of ALPK1, TIFA, and TRAF6 increases upon C. rodentium infection in C3H/HeN, whereas only TIFA is increased in C57BL/6 mice. Bars indicate standard deviation. (f) The abundance of Alpk1 transcript increases in C3H/HeN from 6 DPI, whereas expression of Alpk1 in C57BL/6 is unchanged upon infection. For all qRT‐PCR data, each point represents an individual mouse at 0, 1, 2, 3, 6, and 8 DPI. * P ≤ .05, ** P ≤ .01, *** P ≤ .001, and **** P ≤ .0001 (one‐way ANOVA)
Figure 8Citrobacter rodentium ADP‐hep metabolite induces activation of the ALPK1 pathway. (a) Quantification of TIFAsomes as depicted in (b) following 1, 2, or 3‐hr infection at MOI 200 with WT, ΔescN, ΔhldE, and ΔrfaC C. rodentium; treatment with ADP‐hep (10−7 M) was used as a control. WT C. rodentium and C. rodentium ΔescN similarly activates ALPK1; C. rodentium ΔhldE does not trigger TIFAsome formation whereas C. rodentium ΔrfaC triggers excessive TIFAsomes. Data correspond to the mean and standard deviation of three experiments (*** P ≤ .001 and **** P ≤ 0.0001 [two‐way ANOVA]). (b) Representative images of HeLa‐TIFA‐GFP cells showing TIFAsomes or not following infection with WT, ΔescN, and ΔhldE, C. rodentium (MOI 200), or treatment with ADP‐hep. Blue, DNA; green, TIFA‐GFP; and red, C. rodentium. Scale bar 20 μM
Comparison of Citrobacter rodentium infection signatures in severe and mild disease models
| Host process | Infection signature | Marker | C3H/HeN (severe) | C57BL/6 (mild) |
|---|---|---|---|---|
| Bacterial colonisation | Transition between the caecal establishment and colonic expansion phase | Sporadic colonisation of colonic epithelium | 2 DPI | 4 DPI (Hopkins et al., |
| Steady‐state infection phase | Uniform colonisation of colonic epithelium | 3 DPI | 6 DPI (Hopkins et al., | |
| CFU over 5 × 108 CFU g−1 stool | 3 DPI | 6 DPI (Hopkins et al., | ||
| CCH | IL‐22 (Berger et al., | Increased proliferation zone | 3 DPI | 4 DPI (Hopkins et al., |
| Increased total crypt length | 3 DPI | 6 DPI (Hopkins et al., | ||
| Innate immune response | IL‐22 signalling (Zheng et al., | Increased | 2 DPI | 6 DPI (Hopkins et al., |
| Increased | 2 DPI | 4 DPI (Hopkins et al., | ||
| IL‐22 (Andoh et al., | Increased | 2 DPI | 6 DPI (Hopkins et al., | |
| Increased | 2 DPI | 6 DPI (Hopkins et al., | ||
| IFN‐γ signalling (Saha, Jyothi Prasanna, Chandrasekar, & Nandi, | Increased | 3 DPI | 8 DPI (Hopkins et al., | |
| NF‐κB (Bauernfeind et al., | Increased | 6 DPI | Undetected | |
| Priming of the ALPK1‐TIFA signalling axis | Increased | 6 DPI | Decrease at 8 DPI | |
| Mucosal response | Host defence mechanism against bacterial attachment (Rosenstiel et al., | Increased | 3 DPI | 8 DPI (Hopkins et al., |
| Epithelial response | Loss of differentiated deep crypt secretory cells (Sasaki et al., | Decreased | 3 DPI | 6 DPI (Hopkins et al., |
| Loss of differentiated enterocytes (Kang et al., | Decreased | 3 DPI | 8 DPI (Hopkins et al., | |
| Metabolism | Lactate fermentation (Doherty & Cleveland, | Increased | 8 DPI | Decreased at 3 DPI |
| Increased | 6 DPI | Unchanged |